Are somatic symptoms a legitimate part of the depression profile in prostate cancer patients?

Christopher F. Sharpley, Vicki Bitsika, David R H Christie

Research output: Contribution to journalArticleResearchpeer-review

7 Citations (Scopus)

Abstract

Background: Although depression is often reported in prostate cancer patients, some tests of depression omit the somatic criteria that are listed for Major Depressive Episode, arguing that these may be confounded by the cancer itself. However, this omission may be challenged in terms of the particular somatic symptoms that have been associated with prostate cancer. Therefore, the present study investigated the relative contribution to total depression scores made by the somatic criteria for Major Depressive Episode that were not caused by prostate cancer. Patients and Methods: 491 prostate cancer patients completed the Zung Self-Rating Depression Scale. Data were analysed to compare the predictive power of 5 subsets of depression on patients' total depressive scores. Results: Somatic symptoms were the most powerful predictor of total depression scores, followed by anhedonia and depressed mood, with similar findings for depression clinical status. Emotional symptoms and cognitive confusion were not significant predictors of total depression scores but did predict depression clinical status. Conclusion: Valid and reliable assessment of depression and selection of appropriate treatment options in prostate cancer patients requires consideration of somatic items which match the DSM-IV-TR criteria for Major Depressive Episode.

Original languageEnglish
Pages (from-to)110-114
Number of pages5
JournalOnkologie
Volume36
Issue number3
DOIs
Publication statusPublished - Mar 2013

Fingerprint

Prostatic Neoplasms
Depression
Medically Unexplained Symptoms
Anhedonia
Confusion
Neurobehavioral Manifestations
Diagnostic and Statistical Manual of Mental Disorders
Neoplasms

Cite this

Sharpley, Christopher F. ; Bitsika, Vicki ; Christie, David R H. / Are somatic symptoms a legitimate part of the depression profile in prostate cancer patients?. In: Onkologie. 2013 ; Vol. 36, No. 3. pp. 110-114.
@article{a5fb1334184747e9a7e46a117f94f819,
title = "Are somatic symptoms a legitimate part of the depression profile in prostate cancer patients?",
abstract = "Background: Although depression is often reported in prostate cancer patients, some tests of depression omit the somatic criteria that are listed for Major Depressive Episode, arguing that these may be confounded by the cancer itself. However, this omission may be challenged in terms of the particular somatic symptoms that have been associated with prostate cancer. Therefore, the present study investigated the relative contribution to total depression scores made by the somatic criteria for Major Depressive Episode that were not caused by prostate cancer. Patients and Methods: 491 prostate cancer patients completed the Zung Self-Rating Depression Scale. Data were analysed to compare the predictive power of 5 subsets of depression on patients' total depressive scores. Results: Somatic symptoms were the most powerful predictor of total depression scores, followed by anhedonia and depressed mood, with similar findings for depression clinical status. Emotional symptoms and cognitive confusion were not significant predictors of total depression scores but did predict depression clinical status. Conclusion: Valid and reliable assessment of depression and selection of appropriate treatment options in prostate cancer patients requires consideration of somatic items which match the DSM-IV-TR criteria for Major Depressive Episode.",
author = "Sharpley, {Christopher F.} and Vicki Bitsika and Christie, {David R H}",
year = "2013",
month = "3",
doi = "10.1159/000348531",
language = "English",
volume = "36",
pages = "110--114",
journal = "Onkologie",
issn = "0378-584X",
publisher = "SOLEN S.R.O.",
number = "3",

}

Are somatic symptoms a legitimate part of the depression profile in prostate cancer patients? / Sharpley, Christopher F.; Bitsika, Vicki; Christie, David R H.

In: Onkologie, Vol. 36, No. 3, 03.2013, p. 110-114.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Are somatic symptoms a legitimate part of the depression profile in prostate cancer patients?

AU - Sharpley, Christopher F.

AU - Bitsika, Vicki

AU - Christie, David R H

PY - 2013/3

Y1 - 2013/3

N2 - Background: Although depression is often reported in prostate cancer patients, some tests of depression omit the somatic criteria that are listed for Major Depressive Episode, arguing that these may be confounded by the cancer itself. However, this omission may be challenged in terms of the particular somatic symptoms that have been associated with prostate cancer. Therefore, the present study investigated the relative contribution to total depression scores made by the somatic criteria for Major Depressive Episode that were not caused by prostate cancer. Patients and Methods: 491 prostate cancer patients completed the Zung Self-Rating Depression Scale. Data were analysed to compare the predictive power of 5 subsets of depression on patients' total depressive scores. Results: Somatic symptoms were the most powerful predictor of total depression scores, followed by anhedonia and depressed mood, with similar findings for depression clinical status. Emotional symptoms and cognitive confusion were not significant predictors of total depression scores but did predict depression clinical status. Conclusion: Valid and reliable assessment of depression and selection of appropriate treatment options in prostate cancer patients requires consideration of somatic items which match the DSM-IV-TR criteria for Major Depressive Episode.

AB - Background: Although depression is often reported in prostate cancer patients, some tests of depression omit the somatic criteria that are listed for Major Depressive Episode, arguing that these may be confounded by the cancer itself. However, this omission may be challenged in terms of the particular somatic symptoms that have been associated with prostate cancer. Therefore, the present study investigated the relative contribution to total depression scores made by the somatic criteria for Major Depressive Episode that were not caused by prostate cancer. Patients and Methods: 491 prostate cancer patients completed the Zung Self-Rating Depression Scale. Data were analysed to compare the predictive power of 5 subsets of depression on patients' total depressive scores. Results: Somatic symptoms were the most powerful predictor of total depression scores, followed by anhedonia and depressed mood, with similar findings for depression clinical status. Emotional symptoms and cognitive confusion were not significant predictors of total depression scores but did predict depression clinical status. Conclusion: Valid and reliable assessment of depression and selection of appropriate treatment options in prostate cancer patients requires consideration of somatic items which match the DSM-IV-TR criteria for Major Depressive Episode.

UR - http://www.scopus.com/inward/record.url?scp=84875196502&partnerID=8YFLogxK

U2 - 10.1159/000348531

DO - 10.1159/000348531

M3 - Article

VL - 36

SP - 110

EP - 114

JO - Onkologie

JF - Onkologie

SN - 0378-584X

IS - 3

ER -